254 related articles for article (PubMed ID: 37390512)
1. A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening.
Li J; Li C; Zhang Z; Zhang Z; Wu Z; Liao J; Wang Z; McReynolds M; Xie H; Guo L; Fan Q; Peng J; Tang W
Eur J Med Chem; 2023 Oct; 258():115567. PubMed ID: 37390512
[TBL] [Abstract][Full Text] [Related]
2. SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues.
Carter TR; Milosevich N; Dada L; Shaum JB; Barry Sharpless K; Kitamura S; Erb MA
Bioorg Med Chem; 2024 Apr; 104():117699. PubMed ID: 38608634
[TBL] [Abstract][Full Text] [Related]
3. A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions.
Guo L; Zhou Y; Nie X; Zhang Z; Zhang Z; Li C; Wang T; Tang W
Eur J Med Chem; 2022 Jun; 236():114317. PubMed ID: 35397401
[TBL] [Abstract][Full Text] [Related]
4. Development of selective FGFR1 degraders using a Rapid synthesis of proteolysis targeting Chimera (Rapid-TAC) platform.
Guo L; Liu J; Nie X; Wang T; Ma ZX; Yin D; Tang W
Bioorg Med Chem Lett; 2022 Nov; 75():128982. PubMed ID: 36096343
[TBL] [Abstract][Full Text] [Related]
5. Molecular glues targeting GSPT1 in cancers: A potent therapy.
Zhang D; Lin P; Lin J
Bioorg Chem; 2024 Feb; 143():107000. PubMed ID: 38029571
[TBL] [Abstract][Full Text] [Related]
6. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
7. A Modular Chemistry Platform for the Development of a Cereblon E3 Ligase-Based Partial PROTAC Library.
Almodóvar-Rivera CM; Zhang Z; Li J; Xie H; Zhao Y; Guo L; Mannhardt MG; Tang W
Chembiochem; 2023 Oct; 24(20):e202300482. PubMed ID: 37418320
[TBL] [Abstract][Full Text] [Related]
8. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
Guenette RG; Potts PR
Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
[TBL] [Abstract][Full Text] [Related]
9. A Degron Blocking Strategy Towards Improved CRL4
Bouguenina H; Scarpino A; O'Hanlon JA; Warne J; Wang HZ; Wah Hak LC; Sadok A; McAndrew PC; Stubbs M; Pierrat OA; Hahner T; Cabry MP; Le Bihan YV; Mitsopoulos C; Sialana FJ; Roumeliotis TI; Burke R; van Montfort RLM; Choudhari J; Chopra R; Caldwell JJ; Collins I
Chembiochem; 2023 Dec; 24(23):e202300351. PubMed ID: 37418539
[TBL] [Abstract][Full Text] [Related]
10. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment.
Dann GP; Liu H; Nowak RP; Jones LH
Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755
[TBL] [Abstract][Full Text] [Related]
11. Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery.
Wang Z; Shaabani S; Gao X; Ng YLD; Sapozhnikova V; Mertins P; Krönke J; Dömling A
Nat Commun; 2023 Dec; 14(1):8437. PubMed ID: 38114468
[TBL] [Abstract][Full Text] [Related]
12. Folate-Guided Protein Degradation by Immunomodulatory Imide Drug-Based Molecular Glues and Proteolysis Targeting Chimeras.
Chen H; Liu J; Kaniskan HÜ; Wei W; Jin J
J Med Chem; 2021 Aug; 64(16):12273-12285. PubMed ID: 34378936
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.
Rana S; Mallareddy JR; Singh S; Boghean L; Natarajan A
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771669
[TBL] [Abstract][Full Text] [Related]
14. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
Cowan AD; Ciulli A
Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
Kastl JM; Davies G; Godsman E; Holdgate GA
SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
[TBL] [Abstract][Full Text] [Related]
16. Screening for molecular glues - Challenges and opportunities.
Holdgate GA; Bardelle C; Berry SK; Lanne A; Cuomo ME
SLAS Discov; 2024 Mar; 29(2):100136. PubMed ID: 38104659
[TBL] [Abstract][Full Text] [Related]
17. Emerging mechanisms of targeted protein degradation by molecular glues.
Frere GA; de Araujo ED; Gunning PT
Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
[TBL] [Abstract][Full Text] [Related]
18. Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues.
Ramachandran S; Ciulli A
Curr Opin Struct Biol; 2021 Apr; 67():110-119. PubMed ID: 33271439
[TBL] [Abstract][Full Text] [Related]
19. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores.
Szewczyk SM; Verma I; Edwards JT; Weiss DR; Chekler ELP
J Med Chem; 2024 Jan; 67(2):1327-1335. PubMed ID: 38170610
[TBL] [Abstract][Full Text] [Related]
20. Clinical Translation of Targeted Protein Degraders.
Kong NR; Jones LH
Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
